Appropriate assessment of the functional consequences of platelet cyclooxygenase-1 inhibition by aspirin in vivo

Thrombosis Research

Volumn 133, Issue 5, 2014, Pages 697-698

  Ofosu, Frederick A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 1;

DRUG EFFECTS; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; THROMBOCYTE;

ASPIRIN; BLOOD PLATELETS; CYCLOOXYGENASE 1; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS;

EID: 84898834759     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.11.025     Document Type: Editorial

References (19)

1. C.L. Campbell, S. Smyth, G. Montalescot, and S.R. Steinhubl Aspirin dose for prevention of cardiovascular disease: a systemic review JAMA 297 2007 2018 2024
2. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 1971 232 235
3. M. Hamberg, J. Svensson, and B. Samuelsson Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides Proc Natl Acad Sci U S A 72 1975 2994 2998
4. V. Fuster, and J.M. Sweeny Aspirin: a historical and contemporary therapeutic overview Circulation 123 2011 768 778
5. L.A. Garcia-Rodriguez, and S. Hernandez-Dias Risk of complicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs Am J Epidemiol 159 2004 23 31
6. W. Tomisato, S. Tsutsumi, T. Hoshino, H.J. Hwang, M. Mio, and T. Tsuchiya et al. Role of direct cytotoxic effects NSAIDs in the induction of gastric lesions Biochem Pharmacol 67 2004 575 585
7. C. Patrono, L.A. Garcia-Rodriguez, R. Landolfi, and C. Baigent Low-dose aspirin for the prevention of atherothrombosis N Engl J Med 353 2005 2373 2383
8. C. Sakata, T. Kawasaki, Y. Kato, M. Abe, K.-L. Suzuki, and M. Ohmiya et al. ASP6537, a novel highly selective cyclooxygenase inhibitor, exerts potent antithrombotic effect without "aspirin dilemma" Thromb Res 132 2013 56 62
9. R.R. Gorman, F.A. Fitzpatrick, and O.V. Miller Reciprocal regulation of human platelets cAMP levels by thromboxane A2 and prostacyclin Adv Cyclic Nucleotide Res 9 1978 597 609
10. A.O. Maree, R.J. Curtin, A. Chubb, C. Dolan, D. Cox, and J. O'Brien et al. Cyclooxigenase-1 haplotype modulates platelet response to aspirin J Thromb Haemost 3 2005 2340 2345
11. J. Valles, T.M. Santos, M.P. Fuset, A. Moscardo, M. Ruano, and F. Perez et al. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction Am J Cardiol 99 2007 19 25
12. T.S. Poulsen, S.R. Kristensen, L. Korsholm, T. Haghfelt, B. Jorgensen, and P.B. Licht et al. Variation and importance of aspirin resistance in patients with known cardiovascular disease Thromb Res 120 2007 477 484
13. J.M. Sweeny, D.A. Grong, and V. Fuster Antiplatelet drug "resistance". Part 1. Mechanisms and clinical measurements Nat Rev Cardiol 6 2009 273 283
14. E.R. Grove, A.-M. Hvas, and S.D. Kristensen Immature platelets in patients with acute coronary syndromes Thromb Haemost 101 2009 151 156
15. D. Alexopoulos, I. Xanthopoulou, G. Tsigkas, A. Damelou, K.C. Theodoropoulos, and G. Makris et al. Intrinsic platelet reactivity and thrombus burden in patients with ST-elevation myocardial infarction Thromb Res 131 2013 333 337
16. C. Kasmeridis, S. Apostolakis, and G.Y.H. Lip Aspirin and aspirin resistance in coronary artery disease Curr Opin Pharmacol 13 2013 242 250
17. S.B. Larsen, E.L. Grove, S.D. Kristensen, and A.-M. Hvas Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease Thromb Haemost 109 2013 920 929
18. E.G. Kovacs, E. Katona, Z. Bereczky, N. Homorodi, L. Balogh, and E. Toth et al. New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin: the lack of aspirin resistance among healthy individuals Thromb Res 131 2013 320 324
19. E.G. Kovacs, E. Katona, Z. Bereczky, N. Homorodi, L. Balogh, and E. Toth et al. Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods Thromb Res 133 2014 811 816